×
Surgery Partners Long Term Debt 2013-2024 | SGRY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Surgery Partners long term debt from 2013 to 2024. Long term debt can be defined as the sum of all long term debt fields.
View More
Surgery Partners Long Term Debt 2013-2024 | SGRY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Surgery Partners long term debt from 2013 to 2024. Long term debt can be defined as the sum of all long term debt fields.
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$148.1B
Elevance Health (ELV)
$90.8B
CVS Health (CVS)
$83.7B
Cencora (COR)
$47.6B
DiDi Global (DIDIY)
$23.1B
Natera (NTRA)
$22.8B
ICON (ICLR)
$15.8B
Doximity (DOCS)
$14.3B
BioMerieux (BMXMF)
$14.1B
Revvity (RVTY)
$14B
Viatris (VTRS)
$13B
Solventum (SOLV)
$12.8B
Avantor (AVTR)
$12B
CochLear (CHEOY)
$11.5B
Medpace Holdings (MEDP)
$10.5B
HealthEquity (HQY)
$9.9B
EUROFINS SCIENT (ERFSF)
$9.5B
Sonic Healthcare (SKHHY)
$8.8B
Charles River Laboratories (CRL)
$8.4B
Amplifon S.p.A (AMFPF)
$6.2B
Bausch + Lomb (BLCO)
$5.7B
Organon (OGN)
$3.9B
Sotera Health (SHC)
$3.9B
BrightSpring Health Services (BTSG)
$3.6B
GeneDx Holdings (WGS)
$3.1B
Concentras Parent (CON)
$3B
Alignment Healthcare (ALHC)
$2.7B
Teladoc Health (TDOC)
$2.4B
Ardent Health Partners (ARDT)
$2.1B
Progyny (PGNY)
$2B